Folate-maytansinoids: Target-selective drugs of low molecular weight

International Journal of Cancer

Volumn 73, Issue 6, 1997, Pages 859-864

  Ladino, Cynthia A ^a   Chari, Ravi V J ^a   Bourret, Lizabeth A ^a   Kedersha, Nancy L ^a   Goldmacher, Victor S ^a  

^a IMMUNOGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARRIER PROTEIN; CELL SURFACE RECEPTOR; DRUG DERIVATIVE; FOLATE BINDING PROTEIN; FOLATE-BINDING PROTEIN; MAYTANSINE;

ARTICLE; CELL CULTURE; CELL STRAIN KB; DRUG SCREENING; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; METABOLISM; SYNTHESIS;

ANTINEOPLASTIC AGENTS; CARRIER PROTEINS; DRUG SCREENING ASSAYS, ANTITUMOR; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; KB CELLS; MAYTANSINE; RECEPTORS, CELL SURFACE; TUMOR CELLS, CULTURED;

EID: 0031564203     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(19971210)73:6<859::aid-ijc16>3.0.co;2-%23     Document Type: Article

References (30)

1. ANDERSON, R.G.W., KAMEN, B.A., ROTHBERG, K.G. and LACEY, S.W., Potocytosis: sequestration and transport of small molecules by caveolae. Science, 255, 410-411 (1992).
2. CAMPBELL, I.G., JONES, T.A., FOULKES, W.D. and TROWSDALE, J., Folate-binding protein is a marker for ovarian cancer. Cancer Res., 51, 5329-5338 (1991).
3. CASSIDY, J., NEWELL, D.R., WEDGE, S.R. and CUMMINGS, J., Pharmacokinetics of high molecular weight agents. Cancer Surv., 17, 315-341 (1993).
4. CHARI, R.V.J., JACKEL, K.A., BOURRET, L.A., DERR, S.M.B., TADAYONI, M., MATTOCKS, K.M., SHAH, S.A., LIU, C., BLÄTTLER, W.A. and GOLDMACHER, V.S., Enhancement of the selectivity and antitumor efficacy of a CC-1065 analog through immunoconjugate formation. Cancer Res., 55, 4079-4084 (1995).
5. CHARI, R.V.J., MARTELL, B.A., GROSS, J.L., COOK, S.B., SHAH, S.A., BLÄTTLER, W.A., MCKENZIE, S.J. and GOLDMACHER, V.S., Immunoconjugates containing novel maytansinoids: promising anti-cancer drugs. Cancer Res., 52, 127-131 (1992).
6. COGLIATI, T., BRUSA, P., CANEVARI, S., CALDERA, M., MEZZANZANICA, D., DOSIO, F., CATTEL, L. and COLNAGHI, M.I., Preparation and biological characterization of conjugates consisting of ricin and a tumor-specific non-internalizing Mab. Anticancer Res., 11, 417-422 (1991).
7. CONEY, L.R., MEZZANZANICA, D., SANBORN, D., CASALINI, P., COLNAGHI, M.I. and ZURAWSKI, V.R., Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing. Cancer Res., 54, 2448-2455 (1994).
8. DEBINSKI, W. and PASTAN, I., Recombinant F(ab′) C242-Pseudomonas exotoxin, but not the whole antibody-based immunotoxin, causes regression of a human colorectal tumor xenograft. Clin. Cancer Res., 1, 1015-1022 (1995).
9. DIXON, K.H., MULLIGAN, T., CHUNG, K.-N., ELWOOD, P.C. and COWAN, K.H., Effects of folate receptor expression following stable transfection into wild type and methotrexate transport-deficient ZR-75-1 human breast cancer cells. J. biol. Chem., 267, 24140-24147 (1992).
10. FRANKLIN, W.A., WAINTRUB, M., EDWARDS, D., CHRISTENSEN, K., PRENDEGRAST, P., WOODS, J., BUNN, P.A. and KOLHOUSE, J.F., New anti-lung-cancer antibody cluster 12 reacts with human folate receptors present on adenocarcinoma. Int. J. Cancer. (Suppl. 8), 89-95 (1994).
11. 2, and Fab in tumors. Cancer Res., 49, 5656-5663 (1989).
12. GARIN-CHESA, P., CAMPBELL, I., SAIGO, P.E., LEWIS, J.L., OLD, L.J. and RETTIG, W.J., Trophoblast and ovarian cancer antigen LK26. Amer. J. Pathol., 142, 557-567 (1993).
13. GHETIE, V. and VITETTA, E., Immunotoxins in the therapy of cancer: from bench to clinic. Pharmacol. Ther., 63, 209-234 (1994).
14. GOLDMACHER, V.S., SCOTT, C.F., LAMBERT, J.M., MCINTYRE, G.D., BLÄTTLER, W.A., COLLINSON, A.R., STEWART, J.K., CHONG, L.D., COOK, S., SLAYTER, H.S., BEAUMONT, E. and WATKINS, S., Cytotoxicity of gelonin and its conjugates with antibodies is determined by the extent of their endocytosis. J. Cell. Physiol., 141, 222-234 (1989).
15. HINMAN, L.M., HAMANN, P.R., WALLACE, R., MENENDEZ, A.T., DURR, F.E. and UPESLACIS, J., Preparation and characterization of monoclonal antibody conjugates of the calicheamicins: a novel and potent family of antitumor antibiotics. Cancer Res., 53, 3336-3342 (1993).
16. HOPKINS, C.R. and TROWBRIDGE, I.S., Internalization and processing of transferrin and the transferrin receptor in human carcinoma A 431 cells. J. Cell Biol., 97, 508-521 (1983).
17. JAIN, R.K., Delivery of novel therapeutic agents in tumors: physiological barriers and strategies. J. nat. Cancer Inst., 81, 570-576 (1989).
18. KAMEN, B.A., Folate and antifolate cell binding and accumulation at physiologic folate concentrations. Nut. Cancer Inst. Monogr., 5, 37-39 (1987).
19. LEAMON, C.P. and LOW, P.S., Cytotoxicity of momordin-folate conjugates in cultured human cells. J. biol. Chem., 267, 24966-24971 (1992).
20. LEAMON, C.P., PASTAN, I. and LOW, P.S., Cytotoxicity of folate-Pseudomonas exotoxin conjugates toward tumor cells. J. biol. Chem., 268, 24847-24854 (1993).
21. LIU, C., TADAYONI, B.M., BOURRET, L.A., MATTOCKS, K.M., DERR, S.M., WIDDISON, W.C., KEDERSHA, N.L., ARINIELLO, P.D., GOLDMACHER, V.S., LAMBERT, J.M., BLÄTTLER, W.A. and CHARI, R.V.J., Eradication of large colon tumor xenografts by targeted delivery of maytansinoids. Proc. nat. Acad. Sci. (Wash.), 93, 8618-8623 (1996).
22. NAGY, A., SCHALLY, A.V., ARMATIS, P., SZEPESHAZI, K., HALMOS, G., KOVACS, M., ZARANDI, M., GROOT, K., MIYAZAKI, M., JUNGWIRTH, A. and HORVATH, J., Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent. Proc. nat. Acad. Sci. (Wash.), 93, 7269-7273 (1996).
23. PASTAN, I., CHAUDHARY, V. and FITZGERALD, D.J., Recombinant toxins as novel therapeutic agents. Ann. Rev. Biochem., 61, 331-354 (1992).
24. PIETERSZ, G.A. and KRAUER, K., Antibody-targeted drugs for the therapy of cancer. J. Drug Target., 2, 183-215 (1994).
25. ROSS, J.F., CHAUDHURI, P.K. and RATNAM, M., Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications. Cancer, 73, 2432-2443 (1994).
26. SIROTNAK, F.M., GOUTAS, L.J., JACOBSEN, D.M., MINES, L.S., BARRUECO, J.R., GAUMONT, Y. and KISLIUK, R.L., Carrier-mediated transport of folate compounds in L1210 cells. Biochem. Pharmacol., 36, 1659-1667 (1987).
27. STEIN, R., GOLDENBERG, D.M. and MATTES, M.J., Normal tissue reactivity of four anti-tumor monoclonal antibodies of clinical interest. Int. J. Cancer, 47, 163-169 (1991).
28. VARGA, J.M., ASATO, N., LANDE, S. and LERNER, A.B., Melanotropin-daunomycin conjugate shows receptor-mediated cytotoxicity in cultured murine melanoma cells. Nature (Lond.), 267, 56-58 (1977).
29. WEITMAN, S.D., LARK, L., CONEY, L.R., FORT, D.W., FRASCA, V., ZURAWSKI, V.R. and KAMEN, B.A., Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res., 52, 3396-3401 (1992a).
30. WEITMAN, S.D., WEINBERG, A.G., CONEY, L.R., ZURAWSKI, V.R., JENNINGS, D.S. and KAMEN, B.A., Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis. Cancer Res., 52, 6708-6711 (1992b).